COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 262: Articles 2611-2620  | Next

Data rectification to account for delays in reporting disease incidence with an application to forecasting COVID-19 cases
Abdussalam, Y. A., Roberts, S., Aguilar, J. B., Kercheville, J., Gutierrez, J. B.
10.1101/2024.04.08.24305398 — Posted: 2024-04-12
Incidence and Risk of Post-COVID-19 Thromboembolic Disease and the Impact of Aspirin Prescription; Nationwide Observational Cohort at the US Department of Veteran Affairs.
Ware, A., Veigulis, Z. P., Hoover, P. J., Blumke, T., Ioannou, G. N., Boyko, E. J., Osborne, T.
10.1101/2024.04.10.24305647 — Posted: 2024-04-12
Application of a High-Resolution Melt Assay for Monitoring SARS-CoV-2 Variants in Burkina Faso and Kenya
Greenland-Bews, C., Shah, S., Achieng, M., Badoum, E. S., Bah, Y., Barsosio, H. C., Brazal-Monzo, H., Canizales, J., Drabko, A., Fraser, A. J., Hannan, L., Jarju, S. J., Kabore, J.-M. T., Kujabi, M. A., Lesosky, M., Manneh, J., Marlais, T., Matthewman, J., Nebie, I., Onyango, E. D., Ouedraogo, A., Otieno, K., Serme, S. S., Sirima, S. B., Soulama, B. I., Tangara, B., Tiono, A. B., Wu, W., Sesay, A. K., Adams, E. R., Drakeley, C., ter Kuile, F. O., Soulama, I., Kariuki, S., Allen, D. J., Edwards, T.
10.1101/2024.04.11.24305244 — Posted: 2024-04-12
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysis
Kopel, H., Araujo, A. B., Bogdanov, A., Zeng, N., Winer, I., Winer-Jones, J. P., Lu, T., Marks, M. A., Bonafede, M., Nguyen, V. H., Martin, D., Mansi, J. A.
10.1101/2024.04.10.24305549 — Posted: 2024-04-12
Antibody Responses to SARS-Cov-2 among Health Care Workers of a Tertiary Hospital in North-Eastern, Tanzania
Ibrahim, P. M., Anthony, F., Rwegoshora, K., Mshana, H., Semvua, H., Chilongola, J.
10.1101/2024.04.09.24305582 — Posted: 2024-04-12
COVID-19 vaccines as boosters or first doses: Simulating scenarios to minimize infections and deaths.
El Deeb, O., El Khoury Edde, J.
10.1101/2024.04.12.24305705 — Posted: 2024-04-12
Parametrization of Worldwide Covid-19 data for multiple variants: How is the SAR-Cov2 virus evolving?
Foerster, D., Bhatkar, S., Bhanot, G.
10.1101/2024.04.09.24305557 — Posted: 2024-04-12
MONITORING OF RESPIRATORY VIRUS COINFECTION IN SOUTHERN BRAZIL DURING COVID-19 PANDEMIC
Padilha, D. A., Barazzetti, F. H., Schorner, M. A., Filho, V. B., Kawagoe, E. K., Souza, D. S. M., Bazzo, M. L., Wagner, G., Fongaro, G.
10.1101/2024.04.09.24305542 — Posted: 2024-04-12
Cardiovascular symptoms of PASC are associated with trace-level cytokines that affect the function of human pluripotent stem cell derived cardiomyocytes
Sinclair, J., Vedelago, C., Ryan, F., Carney, M., Redd, M., Lynn, M., Grubor-Bauk, B., Cao, Y., Henders, A., Chew, K. Y., Gilroy, D., Greaves, K., Labzin, L., Ziser, L., Ronacher, K., Wallace, L., Zhang, Y., Macauslane, K., Ellis, D., Rao, S., Burr, L., Bain, A., Schulz, B. L., Li, J., Lynn, D. J., Palpant, N., Wuethrich, A., Trau, M., Short, K.
10.1101/2024.04.11.587623 — Posted: 2024-04-12
Coatomer complex I is required for the transport of SARS-CoV-2 progeny virions from the endoplasmic reticulum-Golgi intermediate compartment
Hirbayashi, A., Muramoto, Y., Takenaga, T., Tsunoda, Y., Wakazaki, M., Sato, M., Fujita-Fujiharu, Y., Nomura, N., Yamauchi, K., Onishi, C., Nakano, M., Toyooka, K., Noda, T.
10.1101/2024.04.10.588984 — Posted: 2024-04-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).